Proffitt & Goodson Inc Novartis Ag Transaction History

Proffitt & Goodson Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$79.7 - $88.13 $3,666 - $4,053	-46 Closed	0 $0
Q4 2020 Jan 25, 2021	SELL	$78.07 - $94.43 $1,092 - $1,322	-14 Reduced 23.33%	46 $4,000
Q3 2020 Oct 28, 2020	SELL	$82.14 - $91.0 $26,284 - $29,120	-320 Reduced 84.21%	60 $5,000
Q2 2020 Aug 05, 2020	BUY	$80.93 - $91.1 $30,753 - $34,618	380 New	380 $33,000

1,426

138M

1.48M

1.54M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $246B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Proffitt & Goodson Inc, based on Form 13F filings with the SEC.

Stay updated on Proffitt & Goodson Inc with notifications on news.